Insights

Niche focus Early-stage biotech with bacteriophage therapeutics targeting vulnerable communities, presenting a compelling mission-driven value proposition for health-focused buyers and grant-funded programs.

Small team agility A lean 2-10 person organization suggests an opportunity to engage directly with senior leadership for strategic partnerships, pilot programs, and fast decision cycles.

Funding momentum Recent funding of approximately $3.4M combined with $1M-$10M revenue signals growth potential and readiness for partnered development, co-funding, or contract research arrangements.

Cloud and data readiness Utilizes AWS and Google Workspace among other tools, indicating receptiveness to cloud-based collaboration, data management, and scalable clinical/commercial workflows.

Global impact angle Focus on bacteriophage products for vulnerable populations opens doors for nonprofit, government, and international health programs, as well as grant-backed partnerships and channel opportunities.

Similar companies to PhagePro

PhagePro Tech Stack

PhagePro uses 8 technology products and services including Amazon Web Services, gstatic.com, Open Graph, and more. Explore PhagePro's tech stack below.

PhagePro's Email Address Formats

PhagePro uses at least 1 email format:
PhagePro Email FormatsExamplePercentage
FLast@phageproinc.comJDoe@phageproinc.com
100%

Frequently Asked Questions

What is PhagePro's official website and social media links?

Minus sign iconPlus sign icon
PhagePro's official website is phageproinc.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does PhagePro generate?

Minus sign iconPlus sign icon
As of November 2026, PhagePro's annual revenue is estimated to be $1M - $10M.

What is PhagePro's SIC code and NAICS code?

Minus sign iconPlus sign icon
PhagePro's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does PhagePro have currently?

Minus sign iconPlus sign icon
As of November 2026, PhagePro has approximately 8 employees across 1 continents, including North America. Key team members include Research Technician: P. S. Explore PhagePro's employee directory with LeadIQ.

What industry does PhagePro belong to?

Minus sign iconPlus sign icon
PhagePro operates in the Biotechnology Research industry.

What technology does PhagePro use?

Minus sign iconPlus sign icon
PhagePro's tech stack includes Amazon Web Services, gstatic.com, Open Graph, Squarespace, NSONE, Squarespace Commerce, Google Workspace and Google Fonts API.

What is PhagePro's email format?

Minus sign iconPlus sign icon
PhagePro's email format typically follows the pattern of FLast@phageproinc.com. Find more PhagePro email formats with LeadIQ.

How much funding has PhagePro raised to date?

Minus sign iconPlus sign icon
As of November 2026, PhagePro has raised $3.4M in funding. The last funding round occurred on May 16, 2025 for $200K.
PhagePro logo

PhagePro

Biotechnology ResearchMassachusetts, United States2-10 Employees

PhagePro is an early-stage biotechnology company focused on developing bacteriophage-based therapeutics, aimed at addressing health needs in vulnerable communities. Based in Medford, Massachusetts, the company operates within the biotechnology research sector and positions itself to offer novel therapeutic options through phage technologies. Its target customers are likely organizations and groups seeking innovative treatments for difficult-to-treat infections, with an emphasis on public health impact in underserved populations. As a small, research-oriented enterprise, PhagePro pursues development efforts in a highly specialized area of biotech, situating itself among peers in the phage therapy space and contributing to the broader field of antimicrobial research. A recent development is not detailed in the provided information beyond the ongoing focus on advancing phage-based therapeutics for global health, with operations located in the New England region of the United States.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
2-10

Section iconFunding & Financials

  • $3.4M

    PhagePro has raised a total of $3.4M of funding over 4 rounds. Their latest funding round was raised on May 16, 2025 in the amount of $200K as a Grant.

  • $1M - $10M

    PhagePro's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.